Trimethyl Chitosan Hydrogel Nanoparticles for Progesterone Delivery in Neurodegenerative Disorders
Open Access
- 6 December 2019
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 11 (12) , 657
Abstract
Progesterone is a sex hormone which shows neuroprotective effects in different neurodegenerative disorders, including Parkinson’s disease, stroke, and Alzheimer’s disease. However, the pharmacokinetic limitations associated with the peripheral administration of this molecule highlight the need for more efficient delivery approaches to increase brain progesterone levels. Since the nose-to-brain administration of mucoadhesive hydrogel nanoparticles is a non-invasive and convenient strategy for the delivery of therapeutics to the central nervous system, in this work, progesterone-loaded hydrogel nanoparticle formulations have been prepared, characterized, and tested in vivo. Nanoparticles, loaded with different progesterone concentrations, have been obtained by polyelectrolyte complex formation between trimethyl chitosan and sodium alginate, followed by ionotropic gelation with sodium tripolyphosphate as a cross-linking agent. All formulations showed a mean diameter ranging from 200 nm to 236 nm, a polydispersity index smaller than 0.23, and a high progesterone encapsulation efficiency (83–95%). The zeta potential values were all positive and greater than 28 mV, thus ensuring nanoparticles stability against aggregation phenomena as well as interaction with negative sialic residues of the nasal mucosa. Finally, in vivo studies on Sprague–Dawley male rats demonstrated a 5-fold increase in brain progesterone concentrations compared to basal progesterone level after 30 min of hydrogel nanoparticle inhalation.Keywords
This publication has 26 references indexed in Scilit:
- Quantitative analysis of drug delivery to the brain via nasal routeJournal of Controlled Release, 2014
- Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditionsProgress in Neurobiology, 2014
- Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window studyBrain, 2013
- Brain distribution and behavioral effects of progesterone and pregnenolone after intranasal or intravenous administrationEuropean Journal of Pharmacology, 2010
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerationsJournal of Pharmaceutical Sciences, 2010
- Trimethyl chitosan and its applications in drug deliveryJournal of Materials Science: Materials in Medicine, 2008
- Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trialCritical Care, 2008
- ProTECT: A Randomized Clinical Trial of Progesterone for Acute Traumatic Brain InjuryAnnals of Emergency Medicine, 2007
- Different routes of progesterone administration and polycystic ovary syndrome: A review of the literatureGynecological Endocrinology, 2005
- Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 miceSynapse, 2001